Related Experiment Video
Updated: May 5, 2026
06:59
Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing
Published on: May 12, 2023
2.0K
ZEB1 in Pancreatic Cancer
Ulrich Wellner1, Thomas Brabletz, Tobias Keck
1Department of General and Visceral Surgery, University of Freiburg, Hugstetter Straße 55, 79106 Freiburg, Germany. tobias.keck@uniklinik-freiburg.de.
Cancers
|November 28, 2013
Summary
ZEB1 drives pancreatic cancer malignancy by inducing epithelial-mesenchymal transition (EMT), promoting cell spread and stemness. It also contributes to drug resistance, highlighting its critical role in this aggressive cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Pancreatic cancer is a highly malignant neoplasm.
- Epithelial-mesenchymal transition (EMT) contributes to the malignant phenotype of pancreatic cancer.
- ZEB1, a transcriptional repressor, induces EMT.
Purpose of the Study:
- To review the biological functions of ZEB1 in pancreatic cancer.
- To explore ZEB1's role in EMT induction and its consequences.
- To discuss ZEB1's involvement in cancer stem cell traits and drug resistance.
Main Methods:
- Literature review of ZEB1's functions in pancreatic cancer.
- Analysis of molecular mechanisms involving ZEB1, EMT, and microRNAs.
- Examination of ZEB1's association with tumor cell dissemination and drug resistance.
Main Results:
- ZEB1 induces EMT, leading to increased tumor cell dissemination.
- ZEB1 antagonism with microRNAs contributes to cancer stem cell traits and the migrating cancer stem cell (MCSC) hypothesis.
- ZEB1 is associated with drug resistance in pancreatic cancer cells.
Conclusions:
- ZEB1 plays a critical role in the progression and malignancy of pancreatic cancer.
- Understanding ZEB1's functions is crucial for developing targeted therapies.
- The ZEB1-microRNA feedback loop is a key regulator of EMT and stemness in pancreatic cancer.
